Nasolabial Folds Clinical Trial
Official title:
A Multicenter, Evaluator-blinded, Randomized, Delayed Treatment Control Group Study of the Safety and Effectiveness of HAC 20L for the Correction of Moderate to Severe Nasolabial Folds
Nasolabial folds (NLF) are the two skin folds that run from each side of the nose to the corners of the mouth. Prominent NLFs distort the contour of the midface, giving a fatigued and aged appearance. Soft tissue fillers can be used to reduce the depth of NLFs and restore a more youthful appearance. The purpose of this study is to evaluate how safe and effective HAC 20L is in the correction of moderate to severe NLF in adult participants. HAC 20L is an investigational drug being developed for the treatment of NLF. There are 2 cohorts in this study. In each cohort participants are assigned to either the treatment group or no-treatment control group. There is a 1 in 3 chance that participants will be assigned to the no-treatment control group. Around 255 adult participants with moderate to severe NLF will be enrolled in the study at approximately 20 sites worldwide. Participants in the treatment group will receive an injection of HAC 20L to the NLF on Day 1 in Cohort 1 and Cohort 2 with the option of re-treatment after completion of Month 12 visit. The control group will receive no treatment but will be offered an optional HAC 20L treatment after 6 months. There may be higher treatment burden for participants in this trial compared to their standard of care. Participants will attend regular visits during the study at a hospital or clinic. The effect of the treatment will be examined by completing effectiveness questionnaires by the subjects, evaluating investigator (EI) and central reviewers as well as monitoring safety assessments such as vital signs, blood tests, injection site responses and adverse events.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01012661 -
Evaluation of Pain With Lidocaine-Mixed Radiesse® Injectable Dermal Filler
|
Phase 4 | |
| Completed |
NCT01115634 -
Autologous Fibroblast Transplantation in Facial Deformities
|
Phase 2 | |
| Completed |
NCT00778531 -
Protocol for the Post-approval Study of ArteFill® for Correction of Nasolabial Folds
|
Phase 4 | |
| Completed |
NCT03932045 -
A Study to Evaluate the Safety and Efficacy of SYB Filler(SF-01) in the Correction of Nasolabial Folds
|
N/A | |
| Completed |
NCT02647853 -
Phase 1 Study to Assess the Safety and Tolerability of TAT4 Gel in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT01069354 -
Evaluation of Pain With Radiesse® With Lidocaine for Nasolabial Folds
|
N/A | |
| Completed |
NCT00797459 -
Safety & Tolerability Study That Compares Restylane to Restylane With Lidocaine While Correcting Wrinkles in the Nasolabial Folds
|
N/A | |
| Completed |
NCT00850889 -
Juvederm Ultra With Lidocaine Compared With Restylane for the Correction of Nasolabial Folds
|
Phase 4 | |
| Not yet recruiting |
NCT06093321 -
A Study Comparing SYB PDO Thread and MINT Lift® for Temporary Nasolabial Fold Improvement
|
N/A | |
| Not yet recruiting |
NCT06295172 -
A Study Comparing Lafullen15 and Lafullen for Temporary Nasolabial Fold Improvement
|
N/A | |
| Completed |
NCT01060943 -
An Efficacy and Safety Study of TheraFill® Versus KOKEN for 3 Months on Nasolabial Folds
|
Phase 3 | |
| Completed |
NCT05612958 -
Efficacy and Safety of a 'Graft/Prosthesis, Biomaterial (DKM410)' in the Treatment of Both Nasolabial Folds
|
N/A | |
| Completed |
NCT02672644 -
Non-comparative Evaluation of Facial Expressions Following Lower Face Correction Using Emervel Classic and Emervel Deep
|
Phase 4 | |
| Completed |
NCT01012388 -
Radiesse® Injectable Dermal Filler for the Treatment of Nasolabial Folds in Persons of Color
|
Phase 4 | |
| Completed |
NCT01635855 -
Belotero Post Approval Study
|
Phase 4 | |
| Completed |
NCT02179736 -
A Post Market Evaluation After Treatment of Nasolabial Folds
|
N/A | |
| Terminated |
NCT00716443 -
Evaluate Efficacy, Safety & Subject Satisfaction of Pain Management With Pliaglis® Cream for Dermal Filler Injections
|
Phase 4 | |
| Recruiting |
NCT02607670 -
Phase 2 Study of TAT4 Gel for Reduction of Nasolabial Folds
|
Phase 2 | |
| Completed |
NCT00823069 -
Safety Study That Compares Perlane to Perlane With Lidocaine (Perlane-L) While Correcting Wrinkles in the Area Around Your Nose
|
N/A | |
| Recruiting |
NCT06367634 -
TEOSYAL® PureSense ULTRA DEEP Versus Restylane® Lidocaine for the Correction of Moderate to Severe Nasolabial Folds in Chinese Adults
|
N/A |